ATW 2020

January 26 - 29, 2021  •  Miami Convention Center

Sponsorship enquiries    Register your interest for 2021

Advanced Therapies Week

Formerly Phacilitate Leaders World

January 26 - 29, 2021  •  Miami Convention Center

Welcome

Connecting the world of Advanced Therapies since 2004

Connecting the world of Advanced Therapies since 2004

Join us in Miami South Beach in January 2021

FIND OUT MORE   STAND ENQUIRY

Stand out in the crowd

Stand out in the crowd

SPONSORSHIP OPPORTUNITIES
Join us in South Beach

Join us in South Beach

REGISTER YOUR INTEREST
A world class audience, year after year

A world class audience, year after year

SEE WHO ATTENDED IN 2020

Welcome to Advanced Therapies Week
previously known as Phacilitate Leaders World

Advanced Therapies Week is the destination for anyone developing, investing or interested in cell and gene therapies and tissue engineered products. Throughout the week, a focused series of events take place that serve everyone from biotechs to big pharma, tech providers to investors, regulators to healthcare professionals, and beyond.

In 2021, Phacilitate are delighted to be moving Advanced Therapies Week to the Miami Convention Center in South Beach, to allow for more attendees and a better event experience than ever before. Stay tuned for more updates as the show begins to take shape.

 

Find out more               Coronavirus Update

Welcome

Let us know you're interested in attending the show by filling out this form

Register here

Check out last year

Take a look at our highlights from the event in January 2020

See the gallery

Sponsor in 2021

From booths to brand positioning there are plenty of opportunities to get yourselves noticed.

Read more

Phacilitate Membership

Join the largest online Advanced Therapies community, and get an exclusive 25% off Phacilitate events!

Become a member

 

Why are we so passionate about advanced therapies?

2019 Speakers

  • Jeanne F. Loring, PhD.

    Jeanne F. Loring, PhD.

    Professor Emeritus/Founder & CSO, Scripps Research Institute/Aspen Neuroscience
  • Matthew Frigault

    Dr Matthew Frigault

    Instructor/Clinical Assistant in Medicine, Massachusetts General Hospital
  • Luca Mussati

    Luca Mussati

    Vice President Pharma and Biotech, Exyte
  • John Moscariello

    John Moscariello

    Senior Director of Viral Vector and Gene Editing Process Development, Celgene
  • Nicole A. Aqui, M.D.

    Nicole A. Aqui, M.D.

    Associate Professor of Clinical Pathology & Laboratory Medicine, Residency Program Director, Chief, Transfusion and Apheresis Services , Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania
  • Joseph Schwartz, MD, MPH.

    Joseph Schwartz, MD, MPH.

    Director, Transfusion Medicine & Cellular Therapy, New York Presbyterian Hospital/Columbia University Medical Center - Blood and Marrow Transplant Program
  • Pascal J. Goldschmidt

    Dr Pascal J. Goldschmidt

    Co-Founder/ Dean Emeritus, Professor of Medicine Emeritus, REGENiSELF/ University of Miami Miller School of Medicine USA
  • Jane C. Andrews

    Dr Jane C. Andrews

    Founder & CEO, Cell Bridge Strategies, LLC
  • Greg Bonfiglio

    Greg Bonfiglio

    Founder & Managing Partner, Proteus, LLC
  • Julie Allickson

    Dr Julie Allickson

    Director, Regenerative Medicine Clinical Center, Wake Forest Regenerative Medicine Institute for Regenerative Medicine / Wake Forest School of Medicine
  • Shashi Murthy

    Dr Shashi Murthy

    CTO and Founder, Flaskworks
  • David Rodriguez

    David Rodriguez

    Director of Business Development, FreeMind Group
  • Frank C Marini

    Frank C Marini

    Professor, Department of Regenerative Medicine, Director, Center for Regenerative Imaging, Wake Forest Institute of Regenerative Medicine
  • Tom Whitehead

    Tom Whitehead

    Co-Founder, Emily Whitehead Foundation
  • Tony Wells

    Tony Wells

    Managing Director, Merit
  • Shabnum Patel

    Shabnum Patel

    Process Development and Manufacturing Scientist, Stanford University
  • Eric Faulkner

    Mr Eric Faulkner

    Vice President, Real World Value and Strategy & Executive Director, Precision and Transformative Medicine COE, Evidera
  • Bernard Siegel, JD.

    Bernard Siegel, JD.

    Executive Director, Regenerative Medicine Foundation
  • Bonghee Lee

    Bonghee Lee

    CEO, nSage/nGene Therapeutics
  • Xuan Yao

    Xuan Yao

    Project manager, Shenzhen Pregene Biopharma

VIEW ALL SPEAKERS

Library couldn't be loaded. It might not be active.

Sponsors & Partners

Loading
  • AES Clean Technology
  • Albumedix
  • Aldevron
  • American Red Cross
  • Aseptic Technologies
  • Be The Match Biotherapies
  • Bio-Techne
  • BioBridge Global
  • Bionique Testing Laboratories Inc
  • Brooks Life Sciences
  • CellGenix
  • Chart Biomedical
  • Charter Medical Ltd
  • Cognate Bioservices
  • Comecer S.p.A
  • Corning Incorporated
  • CPC
  • CRB
  • CryoPort Inc
  • Fresenius Kabi
  • Fujifilm Diosynth Biotechnologies
  • Fujifilm Irvine Scientific
  • G-Con Manufacturing
  • Gemini Bio-Products
  • Global OT/IT Quality Services
  • GPB Scientific, LLC
  • HemaCare Corporation
  • Key Biologics
  • Lonza Ltd
  • MAK System SA
  • Marken
  • Matrixome
  • Merit
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • Nordmark Arzneimittel GmbH & Co. KG
  • Novasep
  • Oxford BioMedica (UK) Ltd
  • Pall Biotech
  • PBS Biotech
  • PendoTECH
  • PHC Corporation of North America
  • Polyplus-Transfection
  • QuickSTAT Global Life Science Logistics
  • Rees Scientific
  • Saint Gobain Performance Plastics (Solon)
  • Sartorius Stedim Biotech
  • Sexton Biotechnologies
  • Signature Biologics
  • StemExpress, LLC
  • Technoflex SA
  • Terumo BCT
  • Thermo Fisher Scientific Inc
  • Vigene Biosciences
  • Werum IT Solutions Inc
  • World Courier Management Ltd

VIEW ALL SPONSORS & PARTNERS

Search

COVID-19 Update

COVID-19 Update - Advanced Therapies Week 2021

The Phacilitate team is monitoring the situation to assess the potential impact of COVID-19 on Advanced Therapies Week 2021 in Miami, and will adapt plans accordingly.

The health and safety of our attendees, sponsors and staff is our utmost priority. We are carefully reviewing various scenarios and protocols to ensure attendees can safely participate. All scenarios and protocols will be in compliance with Miami Beach Convention Center requirements, local and state government official guidelines, as well as the advice of public health experts.

Measures being considered include – but are not limited to – enhanced cleaning program, controlling the crowd density to support appropriate physical distancing, management of traffic flows on the show floor, improved technology to minimize queuing and contact during registration, sanitation stations, and collaborating with venues for improved air filtration.

As the situation continues to evolve, we will keep everyone informed as regulations and guidelines are rolled out. Be sure to check back regularly for updates.

We are looking forward to seeing everyone at the show in January 2021.